Using a substrain of E. coli MG 1655 and nanoscale red blood cell membranes, researchers created tiny biohybrid swimmers that could personalize drug delivery to treat tumors
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection